María G. Kuba

Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

Justin M. Balko, Jennifer M. Giltnane, Kai Wang et al. · Cancer Discovery · 2013 · 477 citations · Full text

Medicine, Cancer Biology, Oncology +17

Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors

Anindita Chakrabarty, Violeta Sánchez, María G. Kuba et al. · Proceedings of the National Academy of Sciences · 2011 · 345 citations

Medicine, Oncology, Pharmacology +17

ERα-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer

Todd W. Miller, Justin M. Balko, Emily M. Fox et al. · Cancer Discovery · 2011 · 337 citations · Full text

Medicine, Molecular Biology, Oncology +17

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

Justin M. Balko, Rebecca S. Cook, David Vaught et al. · Nature Medicine · 2012 · 262 citations · Full text

Medicine, Cancer Biology, Oncology +16

Mutant <i>PIK3CA</i> accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies

Ariella B. Hanker, Adam D. Pfefferle, Justin M. Balko et al. · Proceedings of the National Academy of Sciences · 2013 · 194 citations · Full text

Medicine, Cell Biology, Oncology +16